
Nymox Pharmaceutical (NYMX) Market Capitalization Overview
Market Cap: $5.65M as of Jan 9, 2026
$5.65M
$709.00K (14.37%)past month
As of Jan 9, 2026, Nymox Pharmaceutical (NYMX) has a market capitalization of $5.65M. Over the past 30 days, its market cap has decreased by -33.57%, while in the last 12 months, it has increased by 48.51%.
Market capitalization represents the total value of Nymox Pharmaceutical as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Nymox Pharmaceutical (NYMX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Nymox Pharmaceutical (NYMX) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Nymox Pharmaceutical as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Nymox Pharmaceutical (NYMX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Nymox Pharmaceutical (NYMX) helps investors assess the company's size and compare it with competitors for better investment decisions.
Nymox Pharmaceutical (NYMX) Market Cap & Key Trends
See Nymox Pharmaceutical’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Nymox Pharmaceutical (NYMX)
Order type
Buy in
Order amount
Est. shares
0 shares
Nymox Pharmaceutical (NYMX) Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $6.63M | -42.35% |
| Nov 3, 2025 | $11.50M | +111.11% |
| Oct 1, 2025 | $5.45M | +12.94% |
| Sep 2, 2025 | $4.83M | -37.12% |
| Aug 1, 2025 | $7.67M | -26.27% |
| Jul 1, 2025 | $10.40M | +19.42% |
| Jun 2, 2025 | $8.71M | +3.10% |
| May 1, 2025 | $8.45M | -36.96% |
| Apr 1, 2025 | $13.40M | +58.99% |
| Mar 3, 2025 | $8.43M | +9.88% |
| Feb 3, 2025 | $7.68M | -18.00% |
| Jan 2, 2025 | $9.36M | 0.00% |
Nymox Pharmaceutical (NYMX) End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $5.65M | +48.51% |
| 2025 | $3.81M | -59.37% |
| 2024 | $9.36M | -82.63% |
| 2023 | $53.85M | +82.49% |
| 2022 | $29.51M | -73.23% |
| 2021 | $110.24M | — |
FAQs About Nymox Pharmaceutical (NYMX) Market Cap
As of Jan 9, 2026, the market capitalization of Nymox Pharmaceutical (NYMX) is $5.65M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Nymox Pharmaceutical’s market capitalization has increased by 14.37%, changing from $4.94M to $5.65M as of Jan 9, 2026.
In the last 3 months, Nymox Pharmaceutical’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Nymox Pharmaceutical’s market capitalization decreased from $9.36M in January to $3.81M in December, reflecting a -59.37% change.
In the past five years, Nymox Pharmaceutical (NYMX) has had a compound annual growth rate (CAGR) of -49.01% in market capitalization. This means its market cap has shrunk at an average rate of -49.01% per year.